Allergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 Medications
The Quick Take
– HARMONY IN DIVERSITY is the first study of combined neurotoxin and filler treatment in adults on glucagon-like peptide-1 (GLP-1) medications. In this Phase 4 cohort, participants reported statistically significant improvements in satisfaction with facial appearance and skin quality...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Small businesses hit with Aus Post underpaid postage fees despite photographic evidence - Yahoo Finance Australia
Small businesses hit with Aus Post underpaid postage fees despite photographic evidence Yahoo Finance Australia
Business
GlycoNex Announces Japanese Regulatory Submission for Denosumab Biosimilar SPD8
Regulatory decision in Japan anticipated as early as the end of 2027, subject to PMDA review; GlycoNex continues to seek partners for markets outside Japan NEW…
Business
OceanFirst Financial director Nicos Katsoulis buys $178,277 in stock
Local
Yordenis Ugás announces his new profession in the United States: "Always a Cuban, decent and hard-working." - CiberCuba
Yordenis Ugás announces his new profession in the United States: "Always a Cuban, decent and hard-working." CiberCuba